JTO & JTO CRR

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

JTO & JTO CRR

Jan 4, 2025, 13:45 | Science

Jarushka Naidoo: Phase II TROPICS-03 trial: Sacituzumab Govitecan (TROP2 ADC) in 2L SCLC

Jarushka Naidoo, Thoracic Oncologist at the Beaumont Hospital Dublin (Ireland), shared a recent article by…

Dec 25, 2024, 22:32 | Insight

Stephen Liu: Perioperative osimertinib for resectable EGFR NSCLC

Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post on X: “Perioperative…

Dec 22, 2024, 13:45 | Science

Details on uncommon EGFR mutations in NSCLC from Dr. Alfredo Addeo

Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared a post on X:…

Oct 15, 2024, 16:30 | Blog

Important ad hoc analysis of JCOG 0802 for local recurrence

Elliot Servais, Associate Professor of Surgery, UMass Chan Medical School, Tufts University School of Medicine,…

Oct 7, 2024, 16:46 | Insight

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

Gerry Hanna, Radiation Oncologist at St James's Hospital, shared a post on X: "Very intresting…

Mar 31, 2024, 08:52 | Insight

Stephen Liu: Report on a pilot intervention to inform women undergoing screening

Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared the following insight on…

All: 6 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023